FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308409601> ?p ?o ?g. }

• W4308409601 abstract "Abstract A new series of pyridine, thiazole, and pyrazole analogues were synthesized. The pyridone analogues 4a-e were synthesized by treating N -aryl-2-cyano-3-(4-(diphenylamino)phenyl)acrylamides 3a-e with malononitrile. Many 4-arylidene-thiazolidin-5-one analogues 6a-d were obtained by Knoevenagel reactions of 4-(diphenylamino)benzaldehyde ( 1 ) with their corresponding thiazolidin-5-one derivatives 5a-d . The structural elucidation of the products was proven by the collections of spectroscopic methods such as IR, 1 H NMR, 13 C NMR, and MS data. Their anti-cancer activity was examined against two cell lines, MDA-MB-231 (mammary carcinomas) and A-549 (lung cancer). Compared with cisplatin as a reference standard drug, 6-amino-4-(4-(diphenylamino)phenyl)-2-oxo-1-( p -tolyl)-1,2-dihydropyridine-3,5-dicarbonitrile ( 4b ) and 6-amino-4-(4-(diphenylamino)phenyl)-1-(4-nitrophenyl)-2-oxo-1,2-dihydropyridine-3,5-dicarbonitrile ( 4e ) exhibited better efficiency against the A-549 cell line, with IC 50 = 0.00803 and 0.0095 μM, respectively. Also, these compounds 4b and 4e showed the most potency among the examined compounds against MDA-MB-231 with IC 50 = 0.0103 and 0.0147 μM, respectively. The newly synthesized compounds were docked inside the active sites of the selected proteins and were found to demonstrate proper binding. 2-Cyano-2-(4,4-(diphenylamino)benzylidene)-5-oxo-3-phenylthiazolidin-2-ylidene)- N -( p -tolyl)acetamide ( 6c ) offered the highest binding affinity (− 8.1868 kcal/mol) when docked into (PDB ID:2ITO), in addition to 2-cyano- N -(4-(diethylamino)phenyl)-2-(4-(4-(diphenylamino)benzylidene)-5-oxo-3-phenylthiazolidin-2-ylidene)acetamide ( 6a ) gave the highest energy score (− 9.3507 kcal/mol) with (PDB ID:2A4L)." @default.
• W4308409601 created "2022-11-11" @default.
• W4308409601 creator A5000662902 @default.
• W4308409601 creator A5012653042 @default.
• W4308409601 creator A5026559126 @default.
• W4308409601 creator A5073392152 @default.
• W4308409601 creator A5091414819 @default.
• W4308409601 date "2022-11-07" @default.
• W4308409601 modified "2023-10-09" @default.
• W4308409601 title "Synthesis, biological evaluation and molecular docking of new triphenylamine-linked pyridine, thiazole and pyrazole analogues as anticancer agents" @default.
• W4308409601 cites W1968812902 @default.
• W4308409601 cites W2010320265 @default.
• W4308409601 cites W2025070557 @default.
• W4308409601 cites W2034247546 @default.
• W4308409601 cites W2038445929 @default.
• W4308409601 cites W2040215020 @default.
• W4308409601 cites W2086015449 @default.
• W4308409601 cites W2114918609 @default.
• W4308409601 cites W2278386341 @default.
• W4308409601 cites W2598297903 @default.
• W4308409601 cites W2914921318 @default.
• W4308409601 cites W2942813810 @default.
• W4308409601 cites W2949630018 @default.
• W4308409601 cites W2952538710 @default.
• W4308409601 cites W3007773279 @default.
• W4308409601 cites W3012770371 @default.
• W4308409601 cites W3029020936 @default.
• W4308409601 cites W3044750035 @default.
• W4308409601 cites W3090198873 @default.
• W4308409601 cites W3092338402 @default.
• W4308409601 cites W3094139208 @default.
• W4308409601 cites W3119005666 @default.
• W4308409601 cites W3124165020 @default.
• W4308409601 cites W3124220801 @default.
• W4308409601 cites W3125695503 @default.
• W4308409601 cites W3128646639 @default.
• W4308409601 cites W3135263078 @default.
• W4308409601 cites W3156736390 @default.
• W4308409601 cites W3158369343 @default.
• W4308409601 cites W3165414691 @default.
• W4308409601 cites W3200401036 @default.
• W4308409601 cites W3208231840 @default.
• W4308409601 cites W3214136585 @default.
• W4308409601 cites W4205602022 @default.
• W4308409601 cites W4205893426 @default.
• W4308409601 cites W4206841660 @default.
• W4308409601 cites W4213385095 @default.
• W4308409601 cites W4214935073 @default.
• W4308409601 cites W4220863470 @default.
• W4308409601 cites W4220984322 @default.
• W4308409601 cites W4224290177 @default.
• W4308409601 cites W4281627178 @default.
• W4308409601 cites W4281665149 @default.
• W4308409601 cites W4285189198 @default.
• W4308409601 cites W4293385836 @default.
• W4308409601 doi "https://doi.org/10.1186/s13065-022-00879-x" @default.
• W4308409601 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36345024" @default.
• W4308409601 hasPublicationYear "2022" @default.
• W4308409601 type Work @default.
• W4308409601 citedByCount "5" @default.
• W4308409601 countsByYear W43084096012023 @default.
• W4308409601 crossrefType "journal-article" @default.
• W4308409601 hasAuthorship W4308409601A5000662902 @default.
• W4308409601 hasAuthorship W4308409601A5012653042 @default.
• W4308409601 hasAuthorship W4308409601A5026559126 @default.
• W4308409601 hasAuthorship W4308409601A5073392152 @default.
• W4308409601 hasAuthorship W4308409601A5091414819 @default.
• W4308409601 hasBestOaLocation W43084096011 @default.
• W4308409601 hasConcept C155647269 @default.
• W4308409601 hasConcept C159110408 @default.
• W4308409601 hasConcept C161790260 @default.
• W4308409601 hasConcept C168395250 @default.
• W4308409601 hasConcept C178790620 @default.
• W4308409601 hasConcept C185592680 @default.
• W4308409601 hasConcept C2777682936 @default.
• W4308409601 hasConcept C2777937544 @default.
• W4308409601 hasConcept C2778464347 @default.
• W4308409601 hasConcept C2779485729 @default.
• W4308409601 hasConcept C2780513484 @default.
• W4308409601 hasConcept C41685203 @default.
• W4308409601 hasConcept C71240020 @default.
• W4308409601 hasConcept C71924100 @default.
• W4308409601 hasConcept C75473681 @default.
• W4308409601 hasConceptScore W4308409601C155647269 @default.
• W4308409601 hasConceptScore W4308409601C159110408 @default.
• W4308409601 hasConceptScore W4308409601C161790260 @default.
• W4308409601 hasConceptScore W4308409601C168395250 @default.
• W4308409601 hasConceptScore W4308409601C178790620 @default.
• W4308409601 hasConceptScore W4308409601C185592680 @default.
• W4308409601 hasConceptScore W4308409601C2777682936 @default.
• W4308409601 hasConceptScore W4308409601C2777937544 @default.
• W4308409601 hasConceptScore W4308409601C2778464347 @default.
• W4308409601 hasConceptScore W4308409601C2779485729 @default.
• W4308409601 hasConceptScore W4308409601C2780513484 @default.
• W4308409601 hasConceptScore W4308409601C41685203 @default.
• W4308409601 hasConceptScore W4308409601C71240020 @default.
• W4308409601 hasConceptScore W4308409601C71924100 @default.
• W4308409601 hasConceptScore W4308409601C75473681 @default.
• W4308409601 hasFunder F4320325716 @default.
• W4308409601 hasIssue "1" @default.

• next